関連する実験動画
Updated: Sep 9, 2025

03:20
Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease
Published on: September 22, 2023
1.9K
パーキンソン病の進行,症状,重症に対する食事の影響:ランダム化制御試験のレビュー
Aakash Prasad1, Connie Glover2, Marshal S Shuler1
1Liggins Institute, University of Auckland, Auckland, New Zealand.
The Proceedings of the Nutrition Society
|August 29, 2025
まとめ
パーキンソン病 (PD) の食事介入に関する現在の研究は,症状改善の決定的な証拠が限られていることを示しています. しかし バイオティックサプリメントは PD患者の胃腸疾患の管理に 有望な効果を示しています
科学分野:
- 神経科学
- 栄養学
- 胃腸内科
背景:
- パーキンソン病 (PD) は急速に増加する世界的な神経疾患です.
- 高齢化と産業化が 病例増加に寄与しています
- 現在,PDの治療には病気を修正する薬剤療法はありません.
研究 の 目的:
- パーキンソン病の進行に対する食事介入の影響を検討する.
- 運動と非運動の症状,特に胃腸の問題に対する影響を評価する.
- 病気の全体的な重症度に対する影響を評価する.
主な方法:
- ランダム化制御試験 (RCT) の合成された証拠.
- 食事パターン,個々の食べ物/飲み物,栄養サプリメントに関する研究が含まれています.
- 栄養素,生物活性化合物,バイオティクスを中心に
主要な成果:
- PDの進行,症状,または重症性を改善する食事介入の決定的な証拠は見つかりませんでした.
- 限られたRCTが利用可能であり,さらなる研究が必要であることを示唆しています.
- ビオティックサプリメントは消化器系症状,特に便秘に有益であることが示されました.
結論:
- ダイエット介入はPDの管理における役割を確立するためにより広範なRCTを必要とします.
- バイオティクスのサプリメントは,PD患者の胃腸疾患の症状を緩和するための潜在的な戦略を提供します.
- 食事戦略を通じて患者のケアを最適化するためにさらなる研究が不可欠です.
関連する概念動画
Parkinson's Disease: Treatment
376
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
376
Parkinson's Disease: Overview
702
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
702
Neural Regulation
39.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.9K
Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
413
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
413

